Crossmark

Hyperkinetic disorders and loss of synaptic downscaling

Crossref DOI link: https://doi.org/10.1038/nn.4306

Published Online: 2016-06-28

Published Print: 2016-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Calabresi, Paolo

Pisani, Antonio

Rothwell, John https://orcid.org/0000-0003-1367-6467
Ghiglieri, Veronica

Obeso, Josè A

Picconi, Barbara
License Information

Text and Data Mining valid from 2016-06-28
More Information

Article History

Received: 28 December 2015

Accepted: 18 April 2016

First Online: 28 June 2016

Competing interests

: P.C. receives research support from Bayer Schering, Biogen, Merck Sharp & Dohme, Sanofi-Aventis, and UCB Pharma.